Related Experiment Video
Updated: Aug 14, 2026

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Published on: August 31, 2015
Amoebicidal thymol analogues against brain-eating amoeba, Naegleria fowleri
Meriam Ben Youssef1, Amani Omrani1, Ines Sifaoui2
1Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, 38296 La Laguna, Tenerife, Spain; Laboratory of Functional Physiology and Valorization of Bio-Ressources, Higher Institute of Biotechnology of Beja, University of Jendouba, Beja 382-9000, Tunisia; Instituto Universitario de Bio-Orgánica Antonio González, and Departamento de Química Orgánica, Universidad de La Laguna, Avenida Astrofísico Francisco Sánchez 2, 38206 La Laguna, Tenerife, Spain.
Abstract:
Naegleria fowleri, known as the brain-eating amoeba, is the pathogen parasite that causes primary amoebic meningoencephalitis. None of the currently available therapies are fully effective, mainly due to the inefficacy of pharmacotherapy. In this regard, natural products and related compounds represent a promising strategy for amoebicidal drug discovery. Herein, a series of eight monoterpene phenol derivatives of thymol bearing ester, carbonate, or carbamate moieties were prepared, and screened as potential amoebicidal agents on N. fowleri. The cytotoxicity of these compounds on murine macrophages cell line J774 was also evaluated to assess their selectivity. Compounds 3, 4, 7 and 8 showed significant activity against the N. fowleri trophozoite. Moreover, 4-nitrophenyl thymyl carbonate 8 displayed the highest potency, showing IC50 values of 22.87 and 25.16 μM against N. fowleri trophozoite and cyst stages, respectively, coupled with low cytotoxicity on a mammal cell line. Furthermore, mechanism of action studies revealed that derivative 8 triggered programmed cell death via cytosolic calcium accumulation, mitochondrial alteration, membrane damage, chromatin condensation, and ROS accumulation. In addition, the in-silico ADME analysis indicated that derivative 8 exhibits exceptional drug-likeness meeting all the pharmacokinetic criteria. These results highlight derivative 8 as a promising amoebicidal agent to develop new drugs for the treatment of Naegleria infections.
Insights
New thymol derivatives show promise against the brain-eating amoeba, Naegleria fowleri. Compound 8 effectively killed amoeba stages with low mammal cell toxicity, suggesting potential for new treatments.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Drug Discovery
Background:
- Naegleria fowleri causes fatal primary amoebic meningoencephalitis.
- Current therapies for Naegleria infections are largely ineffective.
- Natural products offer a promising avenue for novel amoebicidal drug development.
Purpose of the Study:
- To synthesize and screen thymol derivatives as potential amoebicidal agents against Naegleria fowleri.
- To evaluate the cytotoxicity and selectivity of these derivatives on mammalian cells.
- To investigate the mechanism of action and pharmacokinetic properties of the most potent compound.
Main Methods:
- Synthesis of eight monoterpene phenol derivatives of thymol.
- Screening of compounds against Naegleria fowleri trophozoites and cysts.
- Cytotoxicity assessment on murine macrophage cell line J774.
- Mechanism of action studies including calcium, mitochondrial, membrane, chromatin, and ROS analysis.
- In-silico ADME analysis for drug-likeness.
Main Results:
- Compounds 3, 4, 7, and 8 demonstrated significant activity against N. fowleri.
- 4-nitrophenyl thymyl carbonate 8 exhibited the highest potency (IC50: 22.87 μM for trophozoites, 25.16 μM for cysts) with low cytotoxicity.
- Derivative 8 induced programmed cell death via multiple cellular pathways.
- In-silico analysis confirmed excellent drug-likeness and pharmacokinetic properties for derivative 8.
Conclusions:
- Thymol derivative 8 is a highly promising candidate for developing new drugs against Naegleria infections.
- The compound's potent amoebicidal activity, low cytotoxicity, and favorable pharmacokinetic profile warrant further investigation.
- This study highlights the potential of natural product derivatives in addressing unmet medical needs for parasitic infections.
More Related Videos
08:54Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
06:55Author Spotlight: Understanding the Propagation of Closed Circular Extrachromosomal rDNA Containing Element (CERE) in Naegleria gruberi
Published on: June 21, 2024
Related Concept Videos
Biological Methods for Microbial Control
Cryptococcal Meningitis
Amebiasis
Antifungal Agents
Anthelminthic Agents
Antiprotozoal Agents